Quadrature Capital Ltd Acquires Shares of 12,071 Revvity, Inc. (NYSE:RVTY)

Quadrature Capital Ltd bought a new position in shares of Revvity, Inc. (NYSE:RVTY) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 12,071 shares of the company’s stock, valued at approximately $1,267,000.

Several other institutional investors also recently bought and sold shares of RVTY. Capital Research Global Investors bought a new position in shares of Revvity during the 4th quarter valued at about $838,080,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Revvity in the fourth quarter worth about $188,368,000. Norges Bank bought a new position in Revvity during the fourth quarter valued at approximately $129,483,000. Northern Trust Corp purchased a new position in Revvity during the 4th quarter valued at approximately $127,401,000. Finally, Dimensional Fund Advisors LP bought a new stake in Revvity in the 4th quarter worth approximately $112,037,000. 86.65% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Revvity

In other news, insider Joel S. Goldberg sold 4,000 shares of the firm’s stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $110.46, for a total value of $441,840.00. Following the sale, the insider now directly owns 36,900 shares in the company, valued at approximately $4,075,974. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.60% of the stock is owned by corporate insiders.

Revvity Stock Up 2.1 %

Shares of RVTY stock traded up $2.34 during mid-day trading on Friday, hitting $115.15. The stock had a trading volume of 1,384,132 shares, compared to its average volume of 833,285. Revvity, Inc. has a 12-month low of $79.50 and a 12-month high of $131.96. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.23 and a quick ratio of 1.92. The firm’s 50-day moving average is $108.82 and its two-hundred day moving average is $106.50. The firm has a market capitalization of $14.21 billion, a P/E ratio of 95.17, a price-to-earnings-growth ratio of 2.94 and a beta of 1.05.

Revvity (NYSE:RVTY) last posted its quarterly earnings results on Monday, April 29th. The company reported $0.98 EPS for the quarter, beating the consensus estimate of $0.94 by $0.04. The business had revenue of $649.90 million during the quarter, compared to analyst estimates of $646.83 million. Revvity had a net margin of 5.49% and a return on equity of 7.37%. The company’s quarterly revenue was down 3.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.01 EPS. On average, analysts predict that Revvity, Inc. will post 4.64 earnings per share for the current fiscal year.

Revvity Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 8th. Investors of record on Friday, October 18th will be paid a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.24%. The ex-dividend date of this dividend is Friday, October 18th. Revvity’s dividend payout ratio (DPR) is currently 23.14%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on RVTY shares. SVB Leerink assumed coverage on shares of Revvity in a report on Monday, July 8th. They issued an “outperform” rating and a $125.00 target price for the company. TD Cowen upped their price objective on Revvity from $123.00 to $130.00 and gave the company a “buy” rating in a research report on Tuesday, April 30th. Leerink Partnrs upgraded Revvity to a “strong-buy” rating in a report on Monday, July 8th. Jefferies Financial Group began coverage on Revvity in a report on Monday, June 3rd. They set a “hold” rating and a $115.00 price target on the stock. Finally, Robert W. Baird lifted their price objective on shares of Revvity from $126.00 to $127.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 30th. Seven equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Revvity presently has a consensus rating of “Moderate Buy” and a consensus price target of $119.14.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.